| FORMAT |
TITLE (click to view) |
 | Exploring the Bidirectional Interactions Between Human Cytomegalovirus and Hepatitis C Virus Replication After Liver Transplantation (2007) |
 | Immunogenicity and Safety of an Experimental Adjuvanted Hepatitis B Candidate Vaccine in Liver Transplant Patients (2006) |
 | Incidence and Risk Factors for the Development of Prolonged and Severe Intrahepatic Cholestasis After Liver Transplantation (2006) |
 | Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics (2006) |
 | Nutritional status and prognosis in cirrhotic patients |
 | Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis (2006) |
 | Liver Transplantation and Recurrent Hepatocellular Carcinoma: Predictive Value of Nodule Size in a Retrospective and Explant Study (2006) |
 | Relief of biliary obstruction due to portal vein cavernoma using a transjugular intrahepatic portosystemic shunt (TIPS) without the need for long-term stenting (2006) |
 | Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis (2006) |
 | Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study (2006). |
 | A systematic review of the quality of liver biopsy specimens (2006) |
 | Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial? (2006) |
 | Transjugular liver biopsy: how good is it for accurate histological interpretation? (2006) |
 | Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis (2006) |
 | King’s Criteria, APACHE II, and SOFA Scores in Acute Liver Failure (2006) |
 | Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation (2006) |
 | An appraisal of the histopathological assessment of liver fibrosis (2006) |
 | Length versus width in liver biopsies |
 | The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays (2006) |
 | Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus |
 | Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres (2006) |
 | 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome (2006) |
 | Is Banding Ligation for Primary Prevention of Variceal Bleeding as Effective as Beta-Blockers, and Is It Safe? (2006) |
 | Transjugular Intrahepatic Portosystemic Shunt (TIPS), the Preferred Therapeutic Option for Budd Chiari Syndrome Associated with Portal Vein Thrombosis (2007) |
 | Risk factors, Sequential Organ Failure Assessment and Model for End-stage Liver Disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit (2007) |
 | Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis |
 | Adrenal insufficiency in liver disease – What is the evidence? |
 | Ultrasound-guided liver biopsy in real life: Comparison of same-day prebiopsy versus real-time ultrasound approach (2007) |
 | Transjugular liver biopsy – Indications, adequacy, quality of specimens, and complications – A systematic review (2007) |
 | An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis. |
 | Towards a Better Liver Transplant Allocation System (2007) |
 | Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC |
 | Transjugular liver biopsy in patientswith di¡use liver disease: comparison of three coreswith one or two cores for accurate histological interpretation (2007) |
 | The effects of glycosaminoglycans on coagulation: a thromboelastographic study (2007) |
 | Noninvasive Tests in the Post–Liver Transplantatio Setting (2007) |
 | CONDUCTION AND EXCITABILITY PROPERTIES OF PERIPHERAL NERVES IN END-STAGE LIVER DISEASE (2007) |
 | Systematic Review of HVPG Measurement: Statistics Versus Clinical Applicability (2007) |
 | Non-invasive tests for liver fibrosis: Encouraging or discouraging results? (2007) |
 | A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation.(2007) |
 | Liver Transplantation for HCV Cirrhosis: Improved Survival in Recent Years and Increased Severity of Recurrent Disease in Female Recipients: Results of a Long Term Retrospective Study (2007) |
 | Repeated courses of transarterial embolization with polyvinyl alcohol particles: ‘long life elixir’ in a cirrhotic patient with unresectable hepatocellular carcinoma (2007) |
 | Different Methods of Creatinine Measurement Significantly Affect MELD Scores (2007) |
 | Transjugular Intrahepatic Portosystemic Shunt for Portal Vein Thrombosis with and Without Underlying Cirrhosis (2007) |
 | Unmasking of -Fetoprotein-Specific CD4 T Cell Responses in Hepatocellular Carcinoma Patients Undergoing Embolization (2007) |
 | Prevention of the development of varices and first portal hypertensive bleeding episode (2007) |
 | Late Intrahepatic Hematoma Complicating Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome (2007) |
 | New insights into the coagulopathy of liver disease and liver transplantation (2006) |
 | The transjugular route: The key hole to the liver world (2007) |
 | Exploring the Bidirectional Interactions Between Human Cytomegalovirus and Hepatitis C Virus Replication After Liver Transplantation (2006) |
 | Primary herpes simplex virus type-2 infection as a cause of liver failure after liver transplantation (2006) |
 | Randomized Controlled Trial of Tacrolimus Versus Microemulsified Cyclosporin (TMC) in Liver Transplantation: Post study Surveillance to 3 Years (2006) |
 | Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized studies (2006) |
 | Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies (2006) |
 | Transjugular intrahepatic portosystemic shunt in the in the management of ascites and hepatorenal syndrome (2006) |
 | The The Low Incidence of Bacterial Infections Could Be a Protective Factor Against Variceal Bleeding Per Se in Hemodynamic Responders to Propranolol (2006) |
 | An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye(2006_ |
 | An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye |
 | Primary Herpes Simplex Virus in type -2 infection as a cause of liver failure after liver transplantation (2006) |
 | Different methods of creatinine measurement significantly affects MELD scores (April 2006) |
 | Conduction and excitability properties of peripheral nerves in end stage liver disease |
| web | Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. May 2006 |
| web | A systematic review of the quality of liver biopsy specimens. May 2006 |
 | An appraisal of the histopathological assessment of liver fibrosis. April 2006 |
 | Length versus width in liver biopsies. April 2006 |
 | Transjugular liver biopsy: how good it is for accurate histological interpretation? April 2006 |
 | Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. April 2006 |
 | King's criteria, APACHE II, and SOFA scores in acute liver failure. April 2006 |
| web | The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays. March 2006 |
 | Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. March 2006 |
 | Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. March 2006 |
 | Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial? March 2006 |
 | Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. March 2006 |
 | Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. March 2006 |
| web | Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. February 2006 |
 | 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. January 2006 |
 | Is banding ligation for primary prevention of variceal bleeding as effective as beta-blockers, and is it safe? January 2006 |
 | Endogenous heparinoids in acute variceal bleeding. January 2006 |
 | Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence. January 2006 |
 | Infection, coagulation, and variceal bleeding in cirrhosis. January 2006 |
 | Monitoring surgical and medical outcomes: the Bernoulli cumulative SUM chart. A novel application to assess clinical interventions. January 2006 |
 | Kinetics of Cytomegalovirus Load Decrease in Solid-Organ Transplant Recipients after Preemptive Therapy with Valganciclovir. January 2006 |
 | Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. January 2006 |
 | Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis. November 2005 |
 | Bleeding ectopic varices—treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation. October 2005 |
 | Systematic review: the model for end-stage liver disease – should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? September 2005 |
 | Antiviral treatment after solid organ transplantation. September 2005 |
 | The relationship between liver function and portal pressure: what comes first, the chicken or the egg? September 2005 |
 | Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantion for HCV cirrhosis. September 2005 |
 | Should we biopsy each liver mass suspicious for HCC before liver transplantation?–No, please don’t. August 2005 |
 | Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen’s disease. July 2005 |
 | Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. May 2005 |
 | MELD is not enough—enough of MELD? April 2005 |
 | Primary prophylaxis of variceal bleeding in cirrhotics unable to take b-blockers: a randomized trial of ligation. March 2005 |
 | Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: A staged prognostic model. January 2005 |
 | Review article: portal vein thrombosis – new insights into aetiology and management. October 2004 |
 | Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years. October 2004 |
 | Extensive Homology between the Major Immunodominant Mitochondrial Antigen in Primary Biliary Cirrhosis and Helicobacter pylori Does Not Lead to Immunological Cross-reactivity. April 2004 |